Page last updated: 2024-08-17

medroxyprogesterone acetate and Pleural Effusion

medroxyprogesterone acetate has been researched along with Pleural Effusion in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kahan, BC; Morris, TP	1
Hackenberg, R; Schulz, KD	1
Murray, DP; O'Sullivan, DJ	1

Reviews

1 review(s) available for medroxyprogesterone acetate and Pleural Effusion

Article	Year
Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids. The Journal of steroid biochemistry and molecular biology, 1996, Volume: 56, Issue:1-6 Spec N Topics: Androgen Antagonists; Androgens; Androstane-3,17-diol; Androstenediol; Antineoplastic Agents, Hormonal; Apolipoproteins; Apolipoproteins D; Breast Neoplasms; Carcinoma; Carrier Proteins; Endometrial Neoplasms; Estrogen Antagonists; Female; Fibrocystic Breast Disease; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Medroxyprogesterone Acetate; Membrane Transport Proteins; Neoplasm Proteins; Pleural Effusion; Receptors, Androgen; Tumor Cells, Cultured	1996

Article

Year

Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids.

The Journal of steroid biochemistry and molecular biology, 1996, Volume: 56, Issue:1-6 Spec N

Topics: Androgen Antagonists; Androgens; Androstane-3,17-diol; Androstenediol; Antineoplastic Agents, Hormonal; Apolipoproteins; Apolipoproteins D; Breast Neoplasms; Carcinoma; Carrier Proteins; Endometrial Neoplasms; Estrogen Antagonists; Female; Fibrocystic Breast Disease; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Medroxyprogesterone Acetate; Membrane Transport Proteins; Neoplasm Proteins; Pleural Effusion; Receptors, Androgen; Tumor Cells, Cultured

1996

Other Studies

2 other study(ies) available for medroxyprogesterone acetate and Pleural Effusion

Article	Year
Improper analysis of trials randomised using stratified blocks or minimisation. Statistics in medicine, 2012, Feb-20, Volume: 31, Issue:4 Topics: Antineoplastic Agents; Back Injuries; Bias; Breast Neoplasms; Carcinoma; Computer Simulation; Data Interpretation, Statistical; Deoxyribonucleases; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Interferon-alpha; Kidney Neoplasms; Liver Cirrhosis, Biliary; Male; Medroxyprogesterone Acetate; Penicillamine; Pleural Effusion; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen; Tissue Plasminogen Activator; Treatment Outcome	2012
Pulmonary tuberous sclerosis responds to progesterone treatment. Irish journal of medical science, 1988, Volume: 157, Issue:6 Topics: Adult; Female; Humans; Lung Diseases; Medroxyprogesterone; Medroxyprogesterone Acetate; Pleural Effusion; Tuberous Sclerosis	1988

Article

Year

Improper analysis of trials randomised using stratified blocks or minimisation.

Statistics in medicine, 2012, Feb-20, Volume: 31, Issue:4

Topics: Antineoplastic Agents; Back Injuries; Bias; Breast Neoplasms; Carcinoma; Computer Simulation; Data Interpretation, Statistical; Deoxyribonucleases; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Interferon-alpha; Kidney Neoplasms; Liver Cirrhosis, Biliary; Male; Medroxyprogesterone Acetate; Penicillamine; Pleural Effusion; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen; Tissue Plasminogen Activator; Treatment Outcome

2012

Pulmonary tuberous sclerosis responds to progesterone treatment.

Irish journal of medical science, 1988, Volume: 157, Issue:6

Topics: Adult; Female; Humans; Lung Diseases; Medroxyprogesterone; Medroxyprogesterone Acetate; Pleural Effusion; Tuberous Sclerosis

1988